Therapeutic Potential of Origanum majorana L. Essential Oil in Diabetes Mellitus: Insights From GC–MS Characterization, In Vivo Hypoglycaemic Studies, and In Silico Analyses
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.71277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Mahmoud Houas und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory For the Study and Development of Water Treatment and Purification Techniques and Environmental Management, Higher Normal School of Kouba, …. Hauptthemen laut MEDLINE: Oils, Volatile, Hypoglycemic Agents, Diabetes Mellitus, Experimental, Origanum. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus is a widespread metabolic disorder characterized by impaired glucose regulation. This study investigated the chemical composition and antidiabetic potential of Origanum majorana essential oil (EO) using integrated in vitro, in vivo, and computational approaches. GC–MS analysis identified 42 constituents representing 96.28% of the oil, with trans‐thujone (33.30%), santolina triene (16.42%), and cis‐verbenyl acetate (15.05%) as the dominant components. In vitro assays revealed strong inhibitory activity against carbohydrate‐hydrolyzing enzymes, with IC 50 values of 3.68 µg/mL for α‐amylase and 4.71 µg/mL for α‐glucosidase, which were lower than those of the reference drug acarbose (11.17 and 9.68 µg/mL, respectively). In vivo evaluation in alloxan‐induced diabetic rats demonstrated a significant reduction in fasting blood glucose levels from 1.47 ± 0.04 g/L in the diabetic group to 0.94 ± 0.03 g/L after EO treatment, accompanied by improvements in biochemical and histopathological parameters. Molecular docking identified several major EO constituents with strong binding affinities toward α‐amylase and α‐glucosidase, particularly cis‐verbenyl acetate (–6.64 and –7.27 kcal/mol) and β‐pinene oxide (–5.40 and –6.46 kcal/mol), exceeding the affinity of acarbose. ADMET analysis predicted favorable pharmacokinetic profiles and low toxicity risks for these compounds. Molecular dynamics simulations confirmed stable protein–ligand interactions, while MM‐PBSA calculations supported strong binding free energies. Density functional theory (DFT) analysis further revealed moderate reactivity and enhanced stability in aqueous environments. Overall, the combined experimental and computational findings suggest that O. majorana EO, particularly its constituents cis‐verbenyl acetate and β‐pinene oxide, represents a promising natural source of antidiabetic agents warranting further pharmacological investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory For the Study and Development of Water Treatment and Purification Techniques and Environmental Management, Higher Normal School of Kouba, Kouba, Algeria.
- Faculty of Exact Sciences, Department of Chemistry, VTRS Laboratory, University of El Oued, El Oued, Algeria.
- Faculty of Exact and Natural Sciences, Department of Matter Sciences, LMCE Laboratory, University of Biskra, Biskra, Algeria.
- Faculty of Material Sciences, Department of Chemistry, LCCE Laboratory, University of Batna-1, Batna, Algeria.
- Department of Chemistry, Faculty of Exact Sciences, University of El Oued, El Oued, Algeria.
- VPRS Laboratory, Department of Chemistry, Faculty of Mathematics and Material Sciences, Kasdi Merbah University, Ouargla, Algeria.
ORCID-Profile: Elhafnaoui Lanez, Yahia Bekkar, Lotfi Bourougaa, Lazhar Bechki, Stefania Garzoli
Zitieren
APA
Houas, M., Benamor, M. L., Lanez, E., Bekkar, Y., Bourougaa, L., Boudebia, O., Bouraoui, R., Adaika, A., Zouaghi, N., Nacer, S. N., Bechki, L., Lanez, T., & Garzoli, S. (2026). Therapeutic Potential of Origanum majorana L. Essential Oil in Diabetes Mellitus: Insights From GC–MS Characterization, In Vivo Hypoglycaemic Studies, and In Silico Analyses. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71277
Vancouver
Houas M, Benamor ML, Lanez E, Bekkar Y, Bourougaa L, Boudebia O, et al. Therapeutic Potential of Origanum majorana L. Essential Oil in Diabetes Mellitus: Insights From GC–MS Characterization, In Vivo Hypoglycaemic Studies, and In Silico Analyses. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71277
BibTeX
@article{Houas2026,
author = {Houas, Mahmoud and Benamor, Mohammed Larbi and Lanez, Elhafnaoui and Bekkar, Yahia and Bourougaa, Lotfi and Boudebia, Ouafa and Bouraoui, Rania and Adaika, Aicha and Zouaghi, Nafila and Nacer, Salah Neghmouche and Bechki, Lazhar and Lanez, Touhami and Garzoli, Stefania},
title = {Therapeutic Potential of Origanum majorana L. Essential Oil in Diabetes Mellitus: Insights From GC–MS Characterization, In Vivo Hypoglycaemic Studies, and In Silico Analyses},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.71277}
}
EUVIMED